Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

A multigenic program mediating breast cancer metastasis to bone.

Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J.

Cancer Cell. 2003 Jun;3(6):537-49.

2.

Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.

Shimo T, Kubota S, Yoshioka N, Ibaragi S, Isowa S, Eguchi T, Sasaki A, Takigawa M.

J Bone Miner Res. 2006 Jul;21(7):1045-59.

3.

The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.

Deckers M, van Dinther M, Buijs J, Que I, Löwik C, van der Pluijm G, ten Dijke P.

Cancer Res. 2006 Feb 15;66(4):2202-9.

5.

Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.

Javelaud D, Mohammad KS, McKenna CR, Fournier P, Luciani F, Niewolna M, André J, Delmas V, Larue L, Guise TA, Mauviel A.

Cancer Res. 2007 Mar 1;67(5):2317-24.

6.

cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.

Son J, Lee JH, Kim HN, Ha H, Lee ZH.

Biochem Biophys Res Commun. 2010 Jul 23;398(2):309-14. doi: 10.1016/j.bbrc.2010.06.087. Epub 2010 Jun 25.

PMID:
20599715
7.

Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.

Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.

Cancer Res. 2007 Sep 15;67(18):8742-51.

8.

Parathyroid hormone-related protein and bone metastases.

Guise TA.

Cancer. 1997 Oct 15;80(8 Suppl):1572-80. Review.

PMID:
9362424
9.

Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.

Reinholz MM, Iturria SJ, Ingle JN, Roche PC.

Breast Cancer Res Treat. 2002 Jun;74(3):255-69.

PMID:
12206515
10.

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.

Capulli M, Angelucci A, Driouch K, Garcia T, Clement-Lacroix P, Martella F, Ventura L, Bologna M, Flamini S, Moreschini O, Lidereau R, Ricevuto E, Muraca M, Teti A, Rucci N.

J Bone Miner Res. 2012 Nov;27(11):2387-98. doi: 10.1002/jbmr.1686.

11.

Development and gene expression profiling of a metastatic variant of the human breast cancer MDA-MB-435 cells.

Bandyopadhyay A, Elkahloun A, Baysa SJ, Wang L, Sun LZ.

Cancer Biol Ther. 2005 Feb;4(2):168-74. Epub 2005 Feb 8.

PMID:
15655343
12.

Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.

Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A.

Breast Cancer Res Treat. 2011 Apr;126(2):373-84. doi: 10.1007/s10549-010-0921-0. Epub 2010 May 13.

PMID:
20464481
13.

E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.

Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T.

Cancer Res. 1996 Sep 1;56(17):4063-70.

14.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
15.

Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis.

Shimo T, Nakanishi T, Nishida T, Asano M, Sasaki A, Kanyama M, Kuboki T, Matsumura T, Takigawa M.

Oncology. 2001;61(4):315-22.

PMID:
11721179
16.

Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors.

Frazier KS, Grotendorst GR.

Int J Biochem Cell Biol. 1997 Jan;29(1):153-61.

PMID:
9076950
17.

Breast cancer bone metastasis: molecular basis of tissue tropism.

Kang Y.

J Musculoskelet Neuronal Interact. 2004 Dec;4(4):379-80. No abstract available.

18.

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD.

Clin Cancer Res. 1999 Sep;5(9):2511-9.

19.

Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.

Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, Suva LJ.

Cancer Res. 2002 Oct 1;62(19):5571-9.

20.

Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.

Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I.

Cancer Res. 2007 Aug 1;67(15):7095-105.

Supplemental Content

Support Center